Abeona Therapeutics Inc. (ABEO)

NASDAQ: ABEO · Real-Time Price · USD

7.13

-0.10 (-1.38%)

At close: Aug 15, 2025, 4:00 PM

7.22

+0.09 (1.26%)

After-hours: Aug 15, 2025, 5:54 PM EDT

Revenue by Product

Fiscal year is January - December.

Fiscal Year	FY 2023	FY 2022	FY 2021	FY 2020	FY 2018	2016 - 2018
Period Ending	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021	Dec '20 Dec 31, 2020	Dec '18 Dec 31, 2018	2016 - 2018
Gene and Cell Therapies	3.50M	Log In	Log In	Log In	Log In	Upgrade
Gene and Cell Therapies Growth	147.52%	Log In	Log In	Log In	Log In	Upgrade

Revenue by Geography

Fiscal year is January - December.

Fiscal Year	FY 2023	FY 2022	FY 2021	FY 2020	FY 2018	2016 - 2018
Period Ending	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021	Dec '20 Dec 31, 2020	Dec '18 Dec 31, 2018	2016 - 2018
United States	3.50M	Log In	Log In	Log In	Log In	Upgrade
United States Growth	147.52%	Log In	Log In	Log In	Log In	Upgrade